Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Medtronic's Hugo robot-assisted surgery system used in gynecological procedure » 09:11
07/29/21
07/29
09:11
07/29/21
09:11
MDT

Medtronic

$130.52 /

+0.295 (+0.23%)

Medtronic announced the…

Medtronic announced the first gynecological procedures with the Hugo robotic-assisted surgery system. The six cases included hysterectomies and myomectomies in Panama City, Panama. Pacifica Salud is the latest institution to join Medtronic's Partners in Possibility Program, a group of hospitals that will be among the first in the world to use the Hugo RAS system. Earlier this month, the hospital announced its first five urological cases with the Hugo RAS system.

ShowHide Related Items >><<
MDT Medtronic
$130.52 /

+0.295 (+0.23%)

MDT Medtronic
$130.52 /

+0.295 (+0.23%)

07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
MDT Medtronic
$130.52 /

+0.295 (+0.23%)

MDT Medtronic
$130.52 /

+0.295 (+0.23%)

MDT Medtronic
$130.52 /

+0.295 (+0.23%)

Wednesday
Hot Stocks
Medtronic announces FDA approval of two AccuRhythm AI algorithms » 08:03
07/28/21
07/28
08:03
07/28/21
08:03
MDT

Medtronic

$130.23 /

+2.15 (+1.68%)

Medtronic announced U.S.…

Medtronic announced U.S. FDA clearance for two AccuRhythm AI algorithms for use with the LINQ II insertable cardiac monitor. AccuRhythm AI applies artificial intelligence to heart rhythm event data collected by LINQ II, improving the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms. AccuRhythm AI validation data will be presented this week at Heart Rhythm 2021, the Heart Rhythm Society's annual Heart Rhythm meeting.

ShowHide Related Items >><<
MDT Medtronic
$130.23 /

+2.15 (+1.68%)

MDT Medtronic
$130.23 /

+2.15 (+1.68%)

07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
MDT Medtronic
$130.23 /

+2.15 (+1.68%)

MDT Medtronic
$130.23 /

+2.15 (+1.68%)

MDT Medtronic
$130.23 /

+2.15 (+1.68%)

Monday
Hot Stocks
Medtronic announces new results from WRAP-IT study » 09:02
07/26/21
07/26
09:02
07/26/21
09:02
MDT

Medtronic

$128.56 /

+1.47 (+1.16%)

Medtronic announced new…

Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm, demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices when the TYRX Absorbable Antibacterial Envelope is used at implant. The analysis showed an 82% reduction in major CIED infections among patients with the TYRX Envelope who developed hematomas compared to patients in the control group who developed hematomas. The key findings, through 36 months of follow-up: In the control group, there was a greater than 11-fold increase in the risk of major infection among patients with hematoma vs. those without hematoma (13.1% vs. 1.6%). In envelope patients, the use of the TYRX Envelope reduced the risk of major infection among patients with hematoma: an 82% reduction in infection compared to control patients with hematoma (2.5% vs. 13.1%).

ShowHide Related Items >><<
MDT Medtronic
$128.56 /

+1.47 (+1.16%)

MDT Medtronic
$128.56 /

+1.47 (+1.16%)

07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
MDT Medtronic
$128.56 /

+1.47 (+1.16%)

MDT Medtronic
$128.56 /

+1.47 (+1.16%)

MDT Medtronic
$128.56 /

+1.47 (+1.16%)

Hot Stocks
Medtronic launches Prevail DCB Catheter in Europe following CE mark » 05:04
07/26/21
07/26
05:04
07/26/21
05:04
MDT

Medtronic

$128.56 /

+1.47 (+1.16%)

Medtronic announced the…

Medtronic announced the launch of the Prevail drug coated balloon, or DCB, Catheter in Europe following CE mark. The Prevail DCB is used during percutaneous coronary intervention, or PCI, procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease, or CAD. During the catheter-based procedure, the balloon inflates within the artery, while the drug is delivered to the arterial tissue where it is absorbed. The Prevail DCB utilizes a rapid absorption drug - paclitaxel - to enable treatment of de novo lesions, small vessel disease, and in-stent restenosis.

ShowHide Related Items >><<
MDT Medtronic
$128.56 /

+1.47 (+1.16%)

MDT Medtronic
$128.56 /

+1.47 (+1.16%)

07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
MDT Medtronic
$128.56 /

+1.47 (+1.16%)

MDT Medtronic
$128.56 /

+1.47 (+1.16%)

MDT Medtronic
$128.56 /

+1.47 (+1.16%)

Over a week ago
Periodicals
Acutus shares would be worth $28 at Atricure's valuation, Kerrisdale says » 09:26
07/21/21
07/21
09:26
07/21/21
09:26
AFIB

Acutus Medical

$13.42 /

+0.03 (+0.22%)

, ATRC

AtriCure

$79.54 /

+2.35 (+3.04%)

, BSX

Boston Scientific

$42.80 /

+1.595 (+3.87%)

, MDT

Medtronic

$125.52 /

+2.75 (+2.24%)

Kerrisdale Capital…

Kerrisdale Capital published a report outlining its long thesis on Acutus Medical (AFIB), in which the firm stated in part: "Despite operating in a multi-billion dollar market growing at high double digit rates, Acutus trades at about 8x the next twelve months' consensus revenue estimates, and at just 5x our 2022 estimate of $76M in revenues, a valuation on par with mega-cap medical device companies like Boston Scientific (BSX) and Medtronic (MDT), and a steep discount to more rapidly growing upstarts. Atricure (ATRC), the only other public company exclusively dedicated to ablation devices, trades at more than 11x consensus estimates for its 2022 revenues despite the fact that its surgical ablation end markets are growing much more slowly than the catheter ablation market, and its core products are existentially threatened by catheter ablation advances. At Atricure's valuation, Acutus shares would be worth $28, more than double their current price, and still offer the prospect of multiplying several times over as AcQMap becomes the standard of care in complex arrhythmias." In pre-market trading, Acutus shares have risen $1.25, or 9%, to $14.69. Reference Link

ShowHide Related Items >><<
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

ATRC AtriCure
$79.54 /

+2.35 (+3.04%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

07/15/21 Canaccord
Acutus Medical upgraded to Buy on signs of commercial traction at Canaccord
07/15/21 Canaccord
Acutus Medical upgraded to Buy from Hold at Canaccord
03/19/21 Canaccord
Acutus Medical price target lowered to $16 from $30 at Canaccord
03/19/21 William Blair
Acutus Medical downgraded to Market Perform from Outperform at William Blair
ATRC AtriCure
$79.54 /

+2.35 (+3.04%)

06/15/21 Stifel
AtriCure price target raised to $85 from $72 at Stifel
05/26/21 SVB Leerink
AtriCure price target raised to $95 from $78 at SVB Leerink
05/14/21 JPMorgan
AtriCure price target raised to $81 from $70 at JPMorgan
04/30/21 Canaccord
AtriCure price target raised to $102 from $77 at Canaccord
BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

06/07/21 Argus
Boston Scientific price target raised to $50 from $45 at Argus
05/26/21
Fly Intel: Top five analyst downgrades
05/26/21 Needham
Boston Scientific downgraded to Hold at Needham on overextended consensus
05/26/21 Needham
Boston Scientific downgraded to Hold from Buy at Needham
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

ATRC AtriCure
$79.54 /

+2.35 (+3.04%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

  • 15
    Jul
  • 06
    Aug
AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

MDT Medtronic
$125.52 /

+2.75 (+2.24%)

BSX Boston Scientific
$42.80 /

+1.595 (+3.87%)

AFIB Acutus Medical
$13.42 /

+0.03 (+0.22%)

Recommendations
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI » 08:27
07/21/21
07/21
08:27
07/21/21
08:27
ISRG

Intuitive Surgical

$955.39 /

+24.39 (+2.62%)

, MDT

Medtronic

$125.52 /

+2.75 (+2.24%)

Evercore ISI analyst…

Evercore ISI analyst Vijay Kumar raised the firm's price target on Intuitive Surgical (ISRG) to $980 from $825 and keeps an In Line rating on the shares. A "big beat was expected" from the company with the stock having a double-digit move up into Q2 earnings, said Kumar, who thinks Intuitive "did enough to meet and beat expectations." He struggles with the stock's multiple, noting that Intuitive currently has a market cap of about $110B and Medtronic (MDT) has a market cap of about $165B. Kumar said it is "hard for us to imagine" Intuitive' smarket cap reaching Medtronic levels given the difference in revenue bases and total addressable markets for the two.

ShowHide Related Items >><<
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

07/21/21 Wells Fargo
Intuitive Surgical price target raised to $1,060 from $916 at Wells Fargo
07/21/21 Baird
Intuitive Surgical price target raised to $1050 from $825 at Baird
07/21/21 Citi
Intuitive Surgical price target raised to $1,100 from $939 at Citi
07/21/21 Piper Sandler
Intuitive Surgical price target raised to $970 from $840 at Piper Sandler
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
06/03/21 Argus
Medtronic price target raised to $150 from $135 at Argus
MDT Medtronic
$125.52 /

+2.75 (+2.24%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

MDT Medtronic
$125.52 /

+2.75 (+2.24%)

ISRG Intuitive Surgical
$955.39 /

+24.39 (+2.62%)

Conference/Events
Needham biopharmaceuticals analysts to hold analyst/industry conference call » 13:25
07/15/21
07/15
13:25
07/15/21
13:25
PCRX

Pacira

$56.07 /

+0.62 (+1.12%)

, HRTX

Heron Therapeutics

$12.99 /

-0.025 (-0.19%)

, ISRG

Intuitive Surgical

$955.93 /

+0.5 (+0.05%)

, MDT

Medtronic

$125.58 /

-2.17 (-1.70%)

, CNMD

Conmed

$127.47 /

-4.69 (-3.55%)

, TELA

Tela Bio

$15.39 /

+ (+0.00%)

, FLXN

Flexion

$6.77 /

-0.105 (-1.53%)

Biopharmaceuticals…

Biopharmaceuticals Analysts Belanger & Matson, along with Key Opinion Leader, Dr. Steve Cohen with NYU Langone Medical Center, discuss the evolving post-op-pain market and robotic surgery technologies on an Analyst/Industry conference call to be held on July 15 at 2 pm.

ShowHide Related Items >><<
TELA Tela Bio
$15.39 /

+ (+0.00%)

PCRX Pacira
$56.07 /

+0.62 (+1.12%)

MDT Medtronic
$125.58 /

-2.17 (-1.70%)

ISRG Intuitive Surgical
$955.93 /

+0.5 (+0.05%)

HRTX Heron Therapeutics
$12.99 /

-0.025 (-0.19%)

FLXN Flexion
$6.77 /

-0.105 (-1.53%)

CNMD Conmed
$127.47 /

-4.69 (-3.55%)

PCRX Pacira
$56.07 /

+0.62 (+1.12%)

06/23/21 Wedbush
Pacira to expand into Latin America with development deal, says Wedbush
04/21/21
Fly Intel: Top five analyst initiations
04/21/21 JPMorgan
Pacira assumed with a Neutral at JPMorgan
04/09/21 Berenberg
Pacira initiated with a Buy at Berenberg
HRTX Heron Therapeutics
$12.99 /

-0.025 (-0.19%)

05/10/21 Cantor Fitzgerald
Cantor Fitzgerald remains bullish on Heron amid HTX-011 labeling discussions
01/21/21 SVB Leerink
Pacira downgraded to Market Perform from Outperform at SVB Leerink
09/08/20 Cowen
Heron Therapeutics' HTX-011 submission to be Class 2, says Cowen
08/14/20 SVB Leerink
SVB Leerink sees $4 per share upside if Heron proposal accepted by FDA
ISRG Intuitive Surgical
$955.93 /

+0.5 (+0.05%)

07/14/21 Stifel
Intuitive Surgical price target raised to $1,060 from $960 at Stifel
06/07/21 Wells Fargo
Intuitive Surgical price target raised to $916 from $892 at Wells Fargo
06/01/21 Evercore ISI
Evercore upgrades Intuitive Surgical to In Line, says 'just wrong' on valuation
06/01/21 Evercore ISI
Intuitive Surgical upgraded to In Line from Underperform at Evercore ISI
MDT Medtronic
$125.58 /

-2.17 (-1.70%)

06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
06/03/21 Argus
Medtronic price target raised to $150 from $135 at Argus
CNMD Conmed
$127.47 /

-4.69 (-3.55%)

07/15/21 UBS
Conmed initiated with a Buy at UBS
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Conmed initiated with an Overweight at Barclays
04/29/21 Piper Sandler
Conmed price target raised to $160 from $145 at Piper Sandler
TELA Tela Bio
$15.39 /

+ (+0.00%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
FLXN Flexion
$6.77 /

-0.105 (-1.53%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
PCRX Pacira
$56.07 /

+0.62 (+1.12%)

MDT Medtronic
$125.58 /

-2.17 (-1.70%)

ISRG Intuitive Surgical
$955.93 /

+0.5 (+0.05%)

HRTX Heron Therapeutics
$12.99 /

-0.025 (-0.19%)

FLXN Flexion
$6.77 /

-0.105 (-1.53%)

CNMD Conmed
$127.47 /

-4.69 (-3.55%)

ISRG Intuitive Surgical
$955.93 /

+0.5 (+0.05%)

PCRX Pacira
$56.07 /

+0.62 (+1.12%)

ISRG Intuitive Surgical
$955.93 /

+0.5 (+0.05%)

FLXN Flexion
$6.77 /

-0.105 (-1.53%)

MDT Medtronic
$125.58 /

-2.17 (-1.70%)

ISRG Intuitive Surgical
$955.93 /

+0.5 (+0.05%)

Options
Medtronic put volume heavy and directionally bearish » 12:15
07/15/21
07/15
12:15
07/15/21
12:15
MDT

Medtronic

$125.81 /

-1.94 (-1.52%)

Bearish flow noted in…

Bearish flow noted in Medtronic with 2,871 puts trading, or 2x expected. Most active are Jul-21 130 calls and Jul-21 125 puts, with total volume in those strikes near 880 contracts. The Put/Call Ratio is 1.61, while ATM IV is up over 1 point on the day. Earnings are expected on August 24th.

ShowHide Related Items >><<
MDT Medtronic
$125.81 /

-1.94 (-1.52%)

MDT Medtronic
$125.81 /

-1.94 (-1.52%)

06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
06/03/21 Argus
Medtronic price target raised to $150 from $135 at Argus
MDT Medtronic
$125.81 /

-1.94 (-1.52%)

MDT Medtronic
$125.81 /

-1.94 (-1.52%)

Conference/Events
Needham biopharmaceuticals analysts to hold analyst/industry conference call » 04:55
07/15/21
07/15
04:55
07/15/21
04:55
PCRX

Pacira

$55.46 /

-0.08 (-0.14%)

, HRTX

Heron Therapeutics

$13.02 /

-0.495 (-3.66%)

, ISRG

Intuitive Surgical

$955.29 /

-1.24 (-0.13%)

, MDT

Medtronic

$127.75 /

+0.36 (+0.28%)

, CNMD

Conmed

$132.06 /

-1.16 (-0.87%)

, TELA

Tela Bio

$15.39 /

-0.09 (-0.58%)

, FLXN

Flexion

$6.87 /

-0.31 (-4.32%)

Biopharmaceuticals…

Biopharmaceuticals Analysts Belanger & Matson, along with Key Opinion Leader, Dr. Steve Cohen with NYU Langone Medical Center, discuss the evolving post-op-pain market and robotic surgery technologies on an Analyst/Industry conference call to be held on July 15 at 2 pm.

ShowHide Related Items >><<
TELA Tela Bio
$15.39 /

-0.09 (-0.58%)

PCRX Pacira
$55.46 /

-0.08 (-0.14%)

MDT Medtronic
$127.75 /

+0.36 (+0.28%)

ISRG Intuitive Surgical
$955.29 /

-1.24 (-0.13%)

HRTX Heron Therapeutics
$13.02 /

-0.495 (-3.66%)

FLXN Flexion
$6.87 /

-0.31 (-4.32%)

CNMD Conmed
$132.06 /

-1.16 (-0.87%)

PCRX Pacira
$55.46 /

-0.08 (-0.14%)

06/23/21 Wedbush
Pacira to expand into Latin America with development deal, says Wedbush
04/21/21
Fly Intel: Top five analyst initiations
04/21/21 JPMorgan
Pacira assumed with a Neutral at JPMorgan
04/09/21 Berenberg
Pacira initiated with a Buy at Berenberg
HRTX Heron Therapeutics
$13.02 /

-0.495 (-3.66%)

05/10/21 Cantor Fitzgerald
Cantor Fitzgerald remains bullish on Heron amid HTX-011 labeling discussions
01/21/21 SVB Leerink
Pacira downgraded to Market Perform from Outperform at SVB Leerink
09/08/20 Cowen
Heron Therapeutics' HTX-011 submission to be Class 2, says Cowen
08/14/20 SVB Leerink
SVB Leerink sees $4 per share upside if Heron proposal accepted by FDA
ISRG Intuitive Surgical
$955.29 /

-1.24 (-0.13%)

07/14/21 Stifel
Intuitive Surgical price target raised to $1,060 from $960 at Stifel
06/07/21 Wells Fargo
Intuitive Surgical price target raised to $916 from $892 at Wells Fargo
06/01/21 Evercore ISI
Evercore upgrades Intuitive Surgical to In Line, says 'just wrong' on valuation
06/01/21 Evercore ISI
Intuitive Surgical upgraded to In Line from Underperform at Evercore ISI
MDT Medtronic
$127.75 /

+0.36 (+0.28%)

06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
06/03/21 Argus
Medtronic price target raised to $150 from $135 at Argus
CNMD Conmed
$132.06 /

-1.16 (-0.87%)

05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Conmed initiated with an Overweight at Barclays
04/29/21 Piper Sandler
Conmed price target raised to $160 from $145 at Piper Sandler
01/28/21 Piper Sandler
Conmed price target raised to $145 from $95 at Piper Sandler
TELA Tela Bio
$15.39 /

-0.09 (-0.58%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
FLXN Flexion
$6.87 /

-0.31 (-4.32%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
PCRX Pacira
$55.46 /

-0.08 (-0.14%)

MDT Medtronic
$127.75 /

+0.36 (+0.28%)

ISRG Intuitive Surgical
$955.29 /

-1.24 (-0.13%)

HRTX Heron Therapeutics
$13.02 /

-0.495 (-3.66%)

FLXN Flexion
$6.87 /

-0.31 (-4.32%)

CNMD Conmed
$132.06 /

-1.16 (-0.87%)

ISRG Intuitive Surgical
$955.29 /

-1.24 (-0.13%)

PCRX Pacira
$55.46 /

-0.08 (-0.14%)

ISRG Intuitive Surgical
$955.29 /

-1.24 (-0.13%)

FLXN Flexion
$6.87 /

-0.31 (-4.32%)

MDT Medtronic
$127.75 /

+0.36 (+0.28%)

ISRG Intuitive Surgical
$955.29 /

-1.24 (-0.13%)

Hot Stocks
Neovasc announces new appointments in leadership » 09:18
07/13/21
07/13
09:18
07/13/21
09:18
NVCN

Neovasc

/

+

, ABT

Abbott

$118.77 /

-0.95 (-0.79%)

, MDT

Medtronic

$128.20 /

+0.06 (+0.05%)

Neovasc (NVCN) announced…

Neovasc (NVCN) announced that it has appointed Lisa Becker as Vice President, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as Vice President, Clinical Affairs. Becker has more than 20 years of experience in medical device regulatory affairs. Her product and therapy experience has spanned medical devices from cardiac rhythm management, to vascular support, pulmonary artery pressure monitoring, cardiac occluders, heart valves and most recently, structural heart products, previously working at Abbott (ABT). Gallagher brings 20 years of medical device clinical research experience to the Neovasc team. Prior to joining Neovasc, she held leadership roles at Medtronic (MDT) in Interventional Pain, Neuromodulation, and Cardiac Rhythm Management, as well as St. Jude Medical in Structural Heart. Neovasc also announces the departure of Vicki Bebeau, former Vice President of Clinical and Regulatory affairs who is assisting with transitioning activities to Sarah and Lisa until August 30, 2021.

ShowHide Related Items >><<
NVCN Neovasc
/

+

MDT Medtronic
$128.20 /

+0.06 (+0.05%)

ABT Abbott
$118.77 /

-0.95 (-0.79%)

NVCN Neovasc
/

+

ABT Abbott
$118.77 /

-0.95 (-0.79%)

07/12/21 Wells Fargo
Abbott price target raised to $135 from $125 at Wells Fargo
07/01/21 Piper Sandler
DexCom settlement with Abbott could be lucrative, says Piper Sandler
07/01/21 Stephens
Stephens says DexCom-Abbott 'legal wrangling' unlikely resolved in short-term
06/04/21 Jefferies
Danaher selloff after Abbott warning overdone, says Jefferies
MDT Medtronic
$128.20 /

+0.06 (+0.05%)

06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
06/03/21 Argus
Medtronic price target raised to $150 from $135 at Argus
MDT Medtronic
$128.20 /

+0.06 (+0.05%)

ABT Abbott
$118.77 /

-0.95 (-0.79%)

ABT Abbott
$118.77 /

-0.95 (-0.79%)

ABT Abbott
$118.77 /

-0.95 (-0.79%)

MDT Medtronic
$128.20 /

+0.06 (+0.05%)

ABT Abbott
$118.77 /

-0.95 (-0.79%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.